A detailed history of Stone House Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Stone House Investment Management, LLC holds 79 shares of BMY stock, worth $4,262. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79
Previous 132 40.15%
Holding current value
$4,262
Previous $7,000 57.14%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $2,133 - $2,808
-53 Reduced 40.15%
79 $3,000
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $6,333 - $7,180
132 New
132 $7,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Stone House Investment Management, LLC Portfolio

Follow Stone House Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone House Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stone House Investment Management, LLC with notifications on news.